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In Brief
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interacting complexes, BRCA1-A,
showing the overall architecture of the
core four-protein assembly and how this
relates to its role as a histone
deubiquitinase in double-stranded DNA
break signaling.
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BRCA1 is a tumor suppressor found to be mutated in
hereditary breast and ovarian cancer and plays key
roles in the maintenance of genomic stability by ho-
mologous recombination repair. It is recruited to
damaged chromatin as a component of the BRCA1-A
deubiquitinase, which cleaves K63-linked ubiquitin
chains attached to histone H2A and H2AX. BRCA1-A
contributes to checkpoint regulation, repair path-
way choice, and HR repair efficiency through molec-
ular mechanisms that remain largely obscure. The
structure of an active core complex comprising
two Abraxas/BRCC36/BRCC45/MERIT40 tetramers
determined by negative-stain electron microscopy
(EM) reveals a distorted V-shape architecture in
which a dimer of Abraxas/BRCC36 heterodimers
sits at the base, with BRCC45/Merit40 pairs
occupying each arm. The location and ubiquitin-
binding activity of BRCC45 suggest that it may pro-
vide accessory interactions with nucleosome-linked
ubiquitin chains that contribute to their efficient pro-
cessing. Our data also suggest how ataxia telangiec-
tasia mutated (ATM)-dependent BRCA1 dimerization
may stabilize self-association of the entire BRCA1-A
complex.INTRODUCTION
Among the various types of genotoxic DNA lesions encountered
by human cells, double-stranded DNA breaks (DSBs) are the
most deleterious, because failure to faithfully repair them can
result in a variety of mutations, including chromosomal rear-
rangements that are characteristic of cancer cells. The repair
of DSBs is achieved by two mechanistically distinct processes:
non-homologous end-joining (NHEJ) and homologous recombi-Cell Repor
This is an open access article undnation (HR). NHEJ is a rapid error-prone repair mechanism
whereby broken ends are directly ligated. In contrast, homolo-
gous recombination (HR) utilizes a sister chromatid to restore
any lost or damaged information in an error-free process that
can only be deployed in the S and G2 phases of the cell cycle
when sister chromatids are present (Daley et al., 2014). A key
player in HR repair is the tumor suppressor BRCA1 (breast can-
cer susceptibility protein 1), which, along with Bard1, is found in
three distinct complexes (BRCA1-A, -B, and –C) that are distin-
guished by virtue of different phospho-dependent interactions of
the Brca1 BRCT-repeats with pSPxF motifs in Abraxas (A),
Bach1/FancJ (B), or CtIP (C) (Wang, 2012). Of these, BRCA1-A
binds to chromatin regions flanking DSBs in a manner depen-
dent upon a cascade of phosphorylation and ubiquitination
events initiated by the MRN complex (Mre11-Rad50-NBS1).
MRN senses the DSB and recruits and activates ATM (ataxia tel-
angiectasia mutated), which, in turn, phosphorylates histone
H2AX on Ser139 (Rogakou et al., 1998). Phosphorylated H2AX
(g-H2AX) is recognized by the BRCT-repeats of MDC1 (mediator
of DNA damage checkpoint 1) (Lou et al., 2006; Stucki et al.,
2005), which, itself, is a substrate of ATM. The subsequent
MDC1-dependent recruitment of the ubiquitin E3 ligases RNF8
and RNF168 together with the E2-conjugating enzyme UBC13/
MMS2 ultimately results in K63-linked polyubiquitination of his-
tones H2A and H2AX (Al-Hakim et al., 2010; Kolas et al., 2007;
Panier and Durocher, 2009). These ubiquitin (Ub) chains then
provide the binding site for the ubiquitin-interacting motif (UIM)
of the fifth BRCA1-A component, Rap80 (Sato et al., 2009). In
addition to Rap80 and the BRCA1/BARD1 heterodimer, the
BRCA1-A complex further comprises a catalytic deubiquitinase
(DUB) core assembly of Abraxas/CCDC98, BRCC36, BRCC45/
BRE, and Merit40/Nba1 (Feng et al., 2009; Hu et al., 2011;
Shao et al., 2009b; Wang et al., 2009) that specifically targets
and removes K63-linked ubiquitin chains from histones flanking
the DSB, thus antagonizing the Mdc1/RNF8/RNF168 cascade
and suppressing repair by HR (Shao et al., 2009a; Wang et al.,
2007). BRCC36, BRCC45, and Merit40 proteins are also found
in complex with an Abraxas paralog, Abro1/KIAA0157 (Feng
et al., 2010; Patterson-Fortin et al., 2010), and an adaptorts 17, 3099–3106, December 20, 2016 ª 2016 The Author(s). 3099
er the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Figure 1. The BRCA1-A Complex
(A) Schematic representations of all known com-
ponents of the BRCA1-A and BRISC complexes
showing the location of known domains and rele-
vant sites of post-translational modification. The
Abraxas, BRCC36, BRCC45, and Merit40 com-
ponents used for structural analysis are boxed,
and the domain coloring is maintained throughout.
The C-terminal truncation position of the Abraxas
construct used for further analysis is shown by the
black triangle. The asterisk denotes BRCC36 as
the enzymatically active subunit.
(B) SEC-MALLS and SDS-PAGE analysis (inset)
analysis of the purified BRCA1-A core complex.
UV absorbance at 280 nm is shown in blue, and
the weight-averaged molecular mass across the
peak is shown in black.
(C) Gallery of individual particles from non-cross-
linked BRCA1 complex (upper panel) contributing
to a corresponding selection of 2D averages
(middle panel). The number of particles contrib-
uting to each class sum is 65, 96, 123, 127, and
104 from left to right. Lower panel: alignment of
reprojections of the segment-defined structure
corresponding to half of the crosslinked BRCA1
complex.
(D) Gallery of individual particles from the cross-
linked BRCA1 complex (upper) with a corre-
sponding selection of 2D averages (middle) used
to calculate an initial 3D structure and corresponding reprojections of this structure (lower). The number of particles contributing to each class sum is 378, 265,
278, 277, 224, and 151 from left to right.
(E) Surface representation of the three-dimensional map of the crosslinked BRCA1 complex with segmentation-defined half-complex maps (related by C2
symmetry) shown in gray and purple. The contour level for the surface encloses a volume corresponding to 580 kDa (assuming 1.21 Da/A˚3).
Scale bars, 20 nm (C and D).protein, SHMT2, that is unrelated to Rap80 (Zheng et al., 2013)
(Figure 1A). Together, these form a distinct cytoplasmic DUB
assembly, BRISC (BRCC36 isopeptide complex), that plays a
role in the deubiquitination and stabilization of the type I inter-
feron receptor (Zheng et al., 2013). Within both BRCA1-A and
BRISC, catalytic activity is provided by BRCC36, a member
of the JAMM/MPN+ (Jacq et al., 2013; Komander et al.,
2009a) Zn2+ metalloprotease-like class of deubiquitinases.
Like many other members of this family, BRCC36 is activated
though pairing with a partner protein containing an inactive
MPN domain (MPN), Abraxas in BRCA1-A, and Abro1 in
BRISC. Structural and biochemical analysis of insect Abro1/
BRCC36 complexes has elegantly shown how BRCC36 is allo-
sterically activated by Abro1 binding (Zeqiraj et al., 2015) and
how this heterodimeric complex self-associates to form a tight
tetrameric assembly, referred to as a ‘‘superdimer’’. Nonethe-
less, a molecular description of the overall architecture of either
the BRCA1-A or BRISC complexes remains elusive. Here, we
present the structure of a catalytically active BRCA1-A core
complex consisting of Abraxas, Brcc36, Brcc45, and Merit40
determined by single particle negative-stain electron micro-
scopy (EM). Our data provide important insights into the struc-
tural and functional contributions of constituent subunits to
BRCA1-A function as a histone deubiquitinase and further sug-
gest a structural basis for ATM-dependent BRCA1 dimerization
(Wu et al., 2016) in regulation of the BRCA1-A complex after
DNA-damage.3100 Cell Reports 17, 3099–3106, December 20, 2016RESULTS
In order to produce BRCA1-A complex samples for structural
and biochemical studies, we took a variety of approaches
focused on co-expression of all or combinations of each of the
subunits and appropriate deletion variants in both Escherichia
coli and insect cell systems. These experiments were, in turn,
guided by the known domain organization of the component pro-
teins and available information about their possible arrange-
ments within the holo-complex (Figure 1A). We were successful
in reconstituting a four-component ‘‘core’’ assembly of Abraxas/
BRCC36/BRCC45/MERIT40 from two bacterially expressed
subcomplexes containing BRCC36 and an Abraxas fragment
(residues 1–269), and full-length BRCC45/MERIT40. BRCC45/
MERIT40 formed a soluble and highly stable association with
1:1 stoichiometry as judged from analysis by multi-angle laser
light scattering with size-exclusion chromatography (SEC-
MALLS) (Figure S1A). However, and in contrast to insect
Abro1/BRCC36 complexes described previously (Zeqiraj et al.,
2015), the human Abraxas/BRCC36 subcomplex behaved as a
soluble aggregate that could not be further purified, but was,
nonetheless, able to form a stable monodispersed and stoichio-
metric assembly when purified in combination with BRCC45/
MERIT40. Thus, it seems likely that the apparent requirement
of BRCC45 for DUB activity of the BRCA1-A complex, but not
BRISC (Patterson-Fortin et al., 2010), is not due to major struc-
tural differences between the two complexes, butmerely reflects
a specific stabilizing effect of BRCC45 on Abraxas/BRCC36
complexes that is not required by Abro1/BRCC36. Regardless,
MALLS analysis of the reconstituted four-component BRCA1-A
complex reported an apparent molecular mass of 280 kDa (Fig-
ure 1B), suggestive of a dimer of Abraxas/BRCC36/BRCC45/
MERIT40 heterotetramers and consonant with the ‘‘super-
dimer’’ originally described for insect Abro1/BRCC36 hetero-
dimers (Zeqiraj et al., 2015). Furthermore, this purified ‘‘super-
tetrameric’’ complex (the ‘‘234’’ complex) displayed substantial
deubiquitinase activity on K63-linked ubiquitin substrates (Fig-
ure S1B), consistent with previous observations that Rap80
is not required for enzymatic activity (Patterson-Fortin et al.,
2010).
Initial analysis by negative-stain electron microscopy showed
substantial sample heterogeneity, consistent with our difficulties
in producing well-diffracting crystals. Nonetheless, they did
reveal the presence of particles with a striking horseshoe or
V-shaped appearance from which we could generate coherent
averages (Figure 1C, top and center panels). In order to stabilize
the complex and improve the quality of the particle fields, we
used the Grafix cross-linking procedure (Stark, 2010). This re-
sulted in a much-improved and essentially homogeneous field
of particles that were, somewhat surprisingly, larger and more
globular than those seen in the non-crosslinked preparations
(Figures 1D and S1C). The resulting reconstruction produced a
volume apparently formed from two interwoven V-shaped as-
semblies closely resembling those seen in the initial specimens
(Figure 1E). This was confirmed by extracting a single V-shaped
sub-volume and comparing suitably aligned reprojections with
the initial class sums generated from the un-crosslinked samples
(Figure 1C, bottom panel). Overall, the particle (the ‘‘434’’
complex) displays clear C2 symmetry and pseudo-D2 symmetry
that is broken by a markedly different arrangement of each of
the stalk regions with respect to the base of the V-shaped
sub-volumes.
In constructing a molecular model of the ‘‘234’’ complex, we
first docked the X-ray structure of the Abro1/BRCC36 super-
dimer (PDB: 5CW3) into the base of the trapezoid such that
the local 2-fold symmetry axis was coincident with that of the
EM volume (Figure 2A). This produced an excellent fit, leaving
a large unfilled volume protruding from each side of the base.
As mentioned, Abraxas and Abro1 each constitute the major
scaffolding components of the nuclear and cytoplasmic ver-
sions of these DUB complexes, respectively. Their cognate
Rap80 and SHMT2 adaptor proteins do not appear to share
the same binding sites and appear to be specific to their respec-
tive core assemblies (Zheng et al., 2013). However, since both
Abraxas and Abro1 each bind to both BRCC36 and BRCC45
in their respective DUB complexes, we surmised that the inter-
action surfaces for these components should show the highest
degree of conservation between the two paralogs. This, indeed,
proved to be the case and beyond the known Brcc36 binding
surface, the only other region of significant homology, covers
a surface on Abraxas that almost exactly coincides with the
stalks of the EM reconstruction, therefore defining the likely in-
teracting region for BRCC45 (Figure 2B). Furthermore, the juxta-
position of the arm region with Abraxas is in agreement with the
experimental determination of the absolute hand of the recon-struction by tilt-series analysis (Figure S2A). By way of confirma-
tion, we carried out native nanospray mass spectrometry on a
subcomplex consisting of only the Abraxas, BRCC45, and
MERIT40 components that we were able to purify, albeit in
limited quantities (Figure 2C). In addition to the heterotrimeric
species, partial dissociation was observed, enabling a pairwise
interaction map to be generated. These data clearly show that
incorporation of BRCC45 and MERIT40 into the BRCA1-A com-
plex is independent of BRCC36, as reported previously (Ng
et al., 2016), and are consistent with a linear association,
whereby BRCC45 forms a bridge between MERIT40 and the
Abraxas scaffold. The VWA (von Willebrand factor type A)
domain core of MERIT40 was therefore modeled into the termi-
nal regions of the arm segments using the crystal structure of
the homologous domain from Rpn10 (PDB: 2X5N; Figure S3A).
This places MERIT40 distant from the catalytic sites, in agree-
ment with the observations that its absence does not signifi-
cantly affect DUB activity in vitro (Patterson-Fortin et al.,
2010). Finally, the N- and C-terminal UEV (Ubc13-E2 variant) do-
mains were modeled using the MMS2 UEV domain coordinates
(PDB: 1J7D; Figure S3B) into the stalk regions contacting
Abraxas and Merit40, respectively (Figure 2D), again in accord
with previous deletion studies (Hu et al., 2011). Only two signif-
icant regions of residual density remain. The first is located
around the MERIT40 VWA domain, presumably arising from
the N- and C-terminal segments not present in the coordinates
used for modeling. The second forms the ‘‘elbow’’ region be-
tween the N- and C-terminal UEV domains of each BRCC45
component, which we assume delineates the position of the
intervening linker.
The location of the BRCC45 UEV domains in the structure is
intriguing. UEV domains are most often found in E2 ubiquitin-
conjugating complexes, where they can act catalytically in the
transthioesterification reaction or provide a non-catalytic ubiqui-
tin (Ub)-binding function that may help to determine linkage
specificity (Komander et al., 2009a). Indeed, using the purified
BRCC45/MERIT40 complex, we have been able to determine
an affinity for binding to K63-linked di-ubiquitin (di-Ub) of around
17 mM using biolayer interferometry (Figure 3A), consistent with
previous glutathione S-transferase (GST) pull-down experiments
(Wang et al., 2009). No VWA domains have been reported to
have Ub-binding activity. Therefore, it seems likely that one or
both BRCC45 UEVs play an accessory role in substrate tethering
by the BRCA1-A core. With this in mind, structural superposition
of one of the BRCC36 molecules from the docked superdimer
with a K63-Ub2 complex of the related MPN
+ DUB, AMSH-LP
(PDB: 2ZNV), enables us to position the ‘‘proximal’’ and ‘‘distal’’
Ub molecules with respect to the BRCC36 active site (Figure 3B;
Zeqiraj et al., 2015). In this context, the proximal Ub is closest to
the substrate and supplies Lys63, which is linked to the C termi-
nus of the distal Ub through the scissile isopeptide bond. In this
arrangement, it is clear that additional Ub units on the distal end
of the chain are directed out into bulk solvent (Figure 3C). How-
ever, the position of the proximal Ub nestles against the surface
of BRCC36, close to the interface with Abraxas. Extending the
chain on both sides using the structure of a K63-linked-Ub dimer
(PDB: 2JF5) shows that the UEV domains from BRCC45 are in
position to provide a potentially extensive accessory interactionCell Reports 17, 3099–3106, December 20, 2016 3101
Figure 2. A Model for the BRCA1-A Core
Complex
(A) Orthogonal views of the 234 complex sub-
volume. Docking of the coordinates of the Abro1/
BRCC36 superdimer (Zeqiraj et al., 2015) into the
base (white surface) defines the two-arm seg-
ments (red surface) as the location of the BRCC45
and MERIT40 components. The bottom image
shows the broken symmetry at the ends of the
complex.
(B) Mapping of sequence alignment of human
Abraxas and Abro1 onto the Abro1/BRCC36
structure reveals a conserved surface patch that
defines the likely site of BRCC45 binding.
(C) Native nanospray MS spectrum of the trimeric
Abraxas/BRCC45/MERIT40 complex (inset). Ex-
perimental and calculated molecular masses for
each of the observed species are shown in the
middle panel, revealing that BRCC45 forms a
bridge between Abraxas and MERIT40 subunits.
(D) Model of the BRCA1-A 234 complex showing
the positions of the Abraxas and BRCC36 super-
dimer in the base, the approximate locations of the
BRCC45 UEV domains in the arm regions, and the
VWA domain of MERIT40 at the apices. BRCC45
and MERIT40 components are shown as semi-
transparent ellipsoidal volumes with ribbon rep-
resentations of the coordinates used for modeling
included for size comparison only. The asterisk
shows the position of the elbow region, which,
presumably, contains the linking region between
the UEV domains of BRCC45. The docking of
atomic coordinates was performed with UCSF
Chimera (Pettersen et al., 2004).surface for ubiquitin molecules on the proximal, but not the
distal, side of the cleavage site.
DISCUSSION
Here, we have described a structural and biochemical analysis of
a core assembly from the human BRCA1-A deubiquitinase com-
plex. Single-particle negative-stain EM reconstructions reveal
the organization of the four components, Abraxas, BRCC36,
BRCC45, and MERIT40, within an unusual V-shaped architec-
ture. The structure now provides a molecular framework within
which functional observations for both the nuclear (BRCA1-A)
and cytoplasmic (BRISC) DUB complexes can be interpreted3102 Cell Reports 17, 3099–3106, December 20, 2016and insights into how these complex deu-
biquitinase assemblies may be regulated.
Previous structural studies have clearly
shown how the BRISC subunit Abro1
binds to and allosterically activates the
DUB activity of BRCC36 and how this
heterodimer further self-associates to
form a ‘‘superdimeric’’ assembly (Zeqiraj
et al., 2015). Given the high degree of
sequence conservation between Abro1
and Abraxas, the similarities in subunit
composition, and, presumably, overallstructures of BRCA1-A and BRISC, it seems likely that the re-
maining common components, BRCC45 and MERIT40, perform
closely related functions in both contexts that, nonetheless,
remain poorly defined at a molecular level. In the case of
BRCC45, our structural analysis now suggests that at least
one of those common functionalities may be in Ub chain interac-
tions. Modeling of the path of the bound Ub substrate (Figure 3B)
shows that, beyond theUb pair bound at the BRCC36 active site,
additional interactions with the core assembly are likely to occur
between the UEV domains of BRCC45 and ubiquitin units on the
side of the chain that is ultimately linked to the modified nucleo-
some. Unlike K48-linked Ub, which shows substantial and
conformationally restrictive Ub-Ub interactions, K63-linked Ub
Figure 3. Ubiquitin Binding by BRCA1-A
(A) Upper panel: binding of di-ubiquitin to the
BRCC45/MERIT40 subcomplex measured by
biolayer interferometry. The top panel shows the
pseudo first-order association constant (Kobs)
plotted against K63-linked Ub2 concentration. The
dissociation equilibrium constant (Kd) of 17 uM
was determined from the ratio of koff and kon.
Lower panel: association and dissociation phases
in the raw kinetic trace for Ub2 binding to a probe
linked to the BRCC45/MERIT40 complex (blue)
and a non-derivatized probe (orange).
(B) Superposition of the AMSH-LP/K63-Ub2
complex with the docked Abro1/BRCC36 struc-
ture shows the approximate positions of the
proximal (teal) and distal (purple) Ubmolecules. As
previously noted (Zeqiraj et al., 2015), the Ins-2
loop that packs against the proximal Ub in AMSH-
LP (yellow) is absent in BRCC36.
(C) The alignment in (A) and the structure of K63-
linked di-ubiquitin were used to model an
extended Ub chain on the proximal and distal
sides of the cleavage site into the 234 complex
(white surface). Abraxas and BRCC36 are shown
in gold and blue, respectively.chains are considerably more flexible (Komander et al., 2009b;
Weeks et al., 2009). While Ub interactions with either of the
two symmetrically arranged BRCC36 components in the 234
assembly is feasible, closer inspection of our modeled Ub com-
plex (Figure 3B) suggests the intriguing possibility that BRCC45
tethers the ubiquitin chain substrate being processed by the
opposing BRCC36 subunit in the 234 complex. This is entirely
consistent with the somewhat unexpected ‘‘half-of-sites’’ activ-
ity reported previously for superdimeric Abro1/BRCC36 and
goes some way to rationalizing the overall architecture of the oc-
tameric 234 complex, with each half of the complex contributing
different but complementary functions. In addition, the utilizationCell Reportsof accessory interactions with Ub units on
the proximal, but not distal, side may
act to retain the DUB complex close to
its substrate following isopeptide bond
cleavage, potentially facilitating subse-
quent processing events.
In contrast to BRCC45, the role of
MERIT40 is less clear. Our structural
data place it at the ends of the two arms
of the V-shaped complex, in contact
with BRCC45, but remote from the
BRCC36, active sites. The flexible asso-
ciation inferred from the EM class sums
derived from the un-crosslinked 234
complex is consistent withMERIT40 teth-
ering to BRCC45 through a PxxR motif in
a C-terminal extension, rather than the
VWA domain itself (Hu et al., 2011; Shao
et al., 2009b). Loss of MERIT40 appears
to destabilize BRCC45 and the BRCA1-A
complex, in general, through an unknownmechanism (Feng et al., 2009; Shao et al., 2009b; Wang et al.,
2009). However, the apparent requirement of MERIT40 for
correct localization of BRCA1-A to DNA-damage foci may
reflect a more direct contribution through interactions of its
VWA domain or N-terminal region with, as yet, unidentified
partners. Indeed, a model of the full hexadecameric 434
complex (Figure 4A) suggests that MERIT40 mediates much
of the overall apparent interaction surface between the constitu-
ent 234 assemblies by stacking against BRCC36 from the
opposing complex (Figure 4A). Chemical cross-linking can often
identify functionally significant complexes formed between mol-
ecules that otherwise interact weakly or transiently, raising the17, 3099–3106, December 20, 2016 3103
Figure 4. Architecture of the 434 Complex
and Brca1 Dimerization
(A) Orthogonal views of a model of the complete
crosslinked 434 particle generated from two
copies of the 234 complex (colored as in Fig-
ure 1A) docked into the EM reconstruction (cyan
mesh). Positions of visible C-termini of the
Abraxas subunits are indicated. Points of closest
approach between BRCC36 (blue) and MERIT40
(wheat are highlighted with dashed circles) are
shown.
(B) Schematic showing a potential cellular role for
ATM-dependent dimerization of BRCA1 in in-
teractions with the 234 (lower left) and the 434
(lower right) complexes. (UIM, ubiquitin-interact-
ing motif; AIR, Abraxas-interacting region.)interesting possibility that a 434-like BRCA1-A supercomplex
may have a physiological role. In this regard, it has been
shown recently that BRCA1 recruitment is stabilized by a DNA
damage-dependent head-to-tail dimerization of its BRCT-repeat
domain mediated by dual phosphorylation of the Abraxas C ter-
minus (Wu et al., 2016; Figure 4B). The location of the Abraxas
C-termini in the 434 particle now suggests that a similar set
of phospho-dependent interactions might stabilize this higher-
order arrangement (Figure 4B), perhaps providing an opportunity
for indirect BRCA1-dependent regulation of deubiquitinase
activity. Furthermore, and given that the 434 complex would
also contain four Rap80 molecules, BRCA1-mediated self-asso-
ciation might also be expected to increase overall avidity for
ubiquitinylated chromatin, potentially allowing fine-tuning of
the amplitude and duration of BRCA1-A activity during the repair
process.EXPERIMENTAL PROCEDURES
Expression and Purification
The BRCA1-A complex core was expressed as two two-component com-
plexes in the E. coli strain BL21(DE3): Abraxas (1-269, N-terminal GST-tag)
with BRCC36 (FL, C-terminal His tag) and BRCC45 (4-383, N-terminal Strep-
tavidin tag) and Merit40 (FL, N-terminal His tag), respectively. Pelleted cells of
both complexes were resuspended together in buffer I (40 mM Tris pH 8.0,
100 mM NaCl, 1 mM TCEP) and lysed using a cell disruptor. Cleared lysate
was loaded on to glutathione-Sepharose 4 Fast Flow (GE Healthcare) equili-
brated with buffer I. Beads were washed with 40 mM Tris pH 8.0, 1 M NaCl,
1 mM TCEP, and the complex was eluted with buffer I supplemented with
20 mM reduced L-glutathione. Pooled fractions were dialysed against
buffer I. The tags of Abraxas, BRCC45, and Merit40 were cleaved with GST-
tagged 3C protease, and the complex was repurified on GST Sepharose to re-
move the protease and any uncleaved complex. Following final purification by
MonoQ anion exchange chromatography and size exclusion chromatography
on Superose 6, the BRCA1-A core complex was concentrated to 20 mg/mL,
shock frozen in liquid nitrogen, and stored at 80C.3104 Cell Reports 17, 3099–3106, December 20, 2016Cross-Linking of the BRCA1-A Complex
Core for Negative-Stain EM
For the cross-linking of the BRCA1-A complex
core, the GraFix method was used (Stark,
2010). Cross-linking was carried out in buffer IV
(40 mM HEPES, pH = 7.5, 100 mM NaCl, 1 mM
TCEP). The 4-component complex (3 mg/mL)
was loaded onto a 10%–30% sucrose/0%–0.1%glutaraldehyde gradient and centrifuged in a SW55 rotor for 16 hr at
30,000 rpm at 4C using a Beckman Coulter Optima L90K ultracentrifuge.
Gradient fractions containing the crosslinked complex were identified by
SDS-PAGE and pooled. Remaining glutaraldehyde was inactivated by the
addition of Tris pH 7.5 to a final concentration of 10 mM, and the combined in-
activated fractions were ‘‘polished’’ by Superose 6 10/300 chromatography
(GE Healthcare).
Sample Preparation for Negative-Stain EM
2 mL of protein (20 mg/mL) was applied to the clean side of carbon on mica
(carbon/mica interface), and the carbon layer was then floated onto PBS
and recovered with a 400 mesh copper grid (TAAB). The grid was immediately
floated onto 1% phosphotungstate solution (pH 7.4) for staining.
Data Collection: Electron Microscopy
Electron microscopy was performed on an FEI Spirit TWIN transmission elec-
tron microscope using a tungsten filament source and operating at 120 kV.
Images were recorded on an Eagle 2K camera at 52 K magnification,
corresponding to a pixel size of 4.3 A˚/pixel at an electron dose of less than
30 e/A˚2 and with a defocus of 1.5 mm.
Image Analysis and 3D Reconstruction
Particles were semi-automatically extracted in 1203120 pixel boxes using the
EMAN2 boxer swarm tool (Tang et al., 2007) and followed bymanual examina-
tion. The non-crosslinked dataset consisted of 1,592 particles, and the cross-
linked dataset consisted of 8,393 particles. Images were filtered to the first
zero of the contrast transfer function (22 A˚). Reference-free 2D alignment, clas-
sification, and averaging of particle images were carried out using IMAGIC
software (van Heel et al., 1996). Initial maps of the crosslinked complex
assuming C2 symmetry were calculated using angular reconstitution and
improved by anchor-set refinement. Deviations from an apparent D2 arrange-
ment for the reconstructed volume were significant and application of higher
symmetry was not justified. This map was masked and filtered to 45 A˚ and
then subsequently refined using Frealign (v9.11) (Lyumkis et al., 2013),
increasing the high-resolution limit of the data used for refinement in 5 A˚ steps
to 30 A˚. To validate the Fourier shell correlation (FSC) curve, the final round of
refinement was repeated using image data with phases greater than 30 A˚ ran-
domized (Chen et al., 2013). The FSC between two maps calculated from
different subsets of particle images provided a resolution estimate of 24.8 A˚
using the 0.143 threshold criterion (Rosenthal and Henderson, 2003). A final
refinement to 27 A˚ produced no further increase in resolution (Figure S2B).
Maps were displayed and the docking of atomic coordinates was performed
with UCSF Chimera (Pettersen et al., 2004). Segmented maps produced
with the Segger-option were used for estimating the volume of the half map
to approximate the non-crosslinked complex. Volumes for the UEV and
VWA domains, blurred to 60 A˚, were generated using pdb2mrc in EMAN.
SEC MALLS Analysis
The BRCA1-A complex core and the two-component complex BRCC45DN4/
Merit40 were analyzed by SEC coupled to multiangle laser light scattering
(SEC-MALLS). Samples (100 mL) were run at concentrations of 1.2 mg/mL
and 1.0 mg/mL, respectively, on a Superose 6 10/300 GL column mounted
on a Jasco HPLC equilibrated in 40 mM Tris pH 8.0, 100 mM NaCl, and
1 mM TCEP at a flow rate of 0.5 mL/min. The scattered light intensity and pro-
tein concentration of the column eluate were recorded using a DAWNHELEOS
laser photometer and anOPTILAB-rEX differential refractometer (DRI) (dn/dc =
0.186), respectively. Data were analyzed using ASTRA software version 6.0.3
(Wyatt Technology).
Native Mass Spectroscopy
Samples were diluted to a concentration of 3 mMprotein in 150mMammonium
acetate pH 7.6 and further buffer-exchanged into 150 mM ammonium
acetate using a Bio-Spin 6 (Bio-Rad) column. The desalted samples were
loaded into in-house-prepared gold-coated glass capillaries. Nano-electro-
spray mass spectrometric analyses were performed under native conditions
on a hybrid quadrupole time-of-flight mass spectrometer previously modified
for high mass transmission. Typical conditions for analysis used capillary,
cone, and CID voltages of 1.6 kV, 80 V, and 20 V. Backing pressure was set
to 4.08e-3 bar.
Binding Analysis
K63-linked di-ubiquitin binding to BRCC45/Merit40 was measured using an
Octet RED biolayer interferometer (Pall ForteBio). His-tagged BRCC45/
Merit40 was immobilized on anti-penta His biosensors (Pall ForteBio) at a con-
centration of approximately 25 mg/mL. The binding of K63-linked di-ubiquitin
(at 5–100 mM) to immobilized BRCC45/MERIT40 was measured at 25C with
a 120 s association step, followed by a 200 s dissociation step in a buffer
containing 40mMTris pH 8.0, 100mMNaCl, and 1mMTCEP. The association
phase was analyzed as a single exponential function using in-house software,
and a plot of the observed rate (kobs) versus ligand concentration gave the
association and dissociation rate constants (kon and koff) as the slope and
intercept, respectively. The equilibrium dissociation constant was determined
as koff/kon.
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